# Eli Lilly Cracking Down on Weight-Loss Drug in Georgia Clinics

> Eli Lilly is shutting down Georgia clinics promoting unapproved weight-loss drug retatrutide.
- Title: Eli Lilly Cracking Down on Weight-Loss Drug in Georgia Clinics
- Summary: Eli Lilly is shutting down Georgia clinics promoting unapproved weight-loss drug retatrutide. Eli Lilly has stopped Georgia clinics from selling unapproved…
- Keywords: eli lilly, retatrutide, georgia, medical facilities, clinical trials, weight loss drug, unapproved drug, food and drug administration, Eli, Lilly, Cracking, Weight-Loss
- Source: Inc — https://inc.com/esther-lian/eli-lilly-cracking-down-experimental-weight-loss-drug-georgia-clinics-promoting-anyway/91422039
- Read time: 1 min
- Topics: eli lilly, retatrutide, georgia, medical facilities, clinical trials, weight loss drug, unapproved drug, food and drug administration
## Eli Lilly's Crackdown
Eli Lilly is cracking down on Georgia clinics promoting unapproved weight-loss drug retatrutide.

> Anything sold to consumers outside of those trials is illegal, with no way to verify its safety, purity or dosing
## At Least 17 Clinics Promote Drug
At least 17 medical facilities in Georgia have advertised or promoted retatrutide, an investigational drug by Eli Lilly.
## Drug Still in Development
Retatrutide is a once-weekly injectable drug that activates receptors for three hormones: GLP-1, GIP, and glucagon.
## Eli Lilly's Stance
Eli Lilly says retatrutide is legally available only through clinical trials and anything sold outside is illegal.

> Anything sold to consumers outside of those trials is illegal, with no way to verify its safety, purity or dosing
## Drug Not FDA Approved
Retatrutide has not been approved by the Food and Drug Administration and is still being studied by Eli Lilly.
## Growing Demand for Weight Loss
About one in eight U.S. adults reported taking a GLP-1 drug for weight loss or another health condition in late 2.025.
## Clinical Trials for Multiple Conditions
Eli Lilly is studying retatrutide for obesity, type 2 diabetes, obstructive sleep apnea, and knee osteoarthritis pain.
## Safety and Effectiveness Under Evaluation
The safety and effectiveness of retatrutide remain under evaluation by Eli Lilly.
## Key takeaway

Eli Lilly has stopped Georgia clinics from selling unapproved weight-loss drug retatrutide despite ongoing clinical trials.